Day: October 4, 2017

Published on: October 03, 2017 at 10:00AM Condition:   Prostate CancerInterventions:   Drug: ARRx;   Drug: PembrolizumabSponsor:   University of Michigan Cancer CenterNot yet recruiting http://ift.tt/2xfbU2r

Published on: October 03, 2017 at 10:00AM Condition:   Elderly Patients Affected by Solid MalignancyIntervention:   Other: QuestionnairesSponsors:   AUSL ROMAGNA;   European Society of Surgical Oncology;   SIOG (International Society...

Published on: October 03, 2017 at 10:00AM Conditions:   Rectal Adenocarcinoma;   Stage III Rectal Cancer AJCC v7;   Stage IIIA Rectal Cancer AJCC v7;   Stage IIIB Rectal Cancer AJCC v7;   Stage IIIC Rectal Cancer AJCC v7;   Stage IV Rectal Cancer AJCC v7;...

Published on: October 03, 2017 at 10:00AM Condition:   Non-Small Cell Lung CancerIntervention:   Other: Will look for immune infiltrationSponsors:   University Hospital of North Norway;   Norwegian Cancer Society;   Northern Health Authority;   St. Olavs Hospital;...

Published on: October 03, 2017 at 10:00AM Condition:   Metastatic CancerInterventions:   Drug: Non Chemotherapy;   Drug: Chemotherapy and target therapy;   Drug: Chinese herb medicineSponsor:   Haining Health-Coming Biotech Co., Ltd.Recruiting http://ift.tt/2xSg1Pb

Published on: October 03, 2017 at 10:00AM Conditions:   Colorectal Adenocarcinoma;   RAS Wild Type;   Stage III Colorectal Cancer AJCC v7;   Stage IIIA Colorectal Cancer AJCC v7;   Stage IIIB Colorectal Cancer AJCC v7;   Stage IIIC Colorectal Cancer AJCC v7;...